Back to Ask the Diabetes Team Ask the Diabetes Team

From New Jersey, USA:

My twelve-year-old daughter was diagnosed with Type 1 diabetes several months ago. Since she was four or five, she has suffered from asthma, has been hospitalized with pneumonia, and has been inflicted with eczema, migraine headaches, urinary tract and yeast infections, chronic sinus infections as well as every other typical childhood "ailment", all while under the medical supervision of her pediatrician and respective specialists.

While I understand that the diabetes is (ostensibly) unrelated to everything else, I can't help but wonder if this is going to be a pattern for the rest of her life. In other words, is it possible that she was born with such a weak immune system that she is more susceptible than the average child? This question has haunted me especially because I have a healthy 14 year-old son who has had little else than asthma. Both were normal pregnancies.


I suspect that your daughter has simply been unlucky. Obviously her pneumonia is related to her asthma and her urine infections, sinus infection and yeast infections could be related to her diabetes. However, in well controlled diabetes there is no reason to have more infections than anyone else.


Original posting 3 Jun 2000
Posted to Other Illnesses


  Back to Ask the Diabetes Team Return to the Top of This Page

Last Updated: Tuesday April 06, 2010 15:09:10
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.